Livongo Announces Preliminary First Quarter 2020 Revenue; Exceeds Previously Announced Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Needham & Company Sees Additional Positive Revisions for Livongo Health Inc. (LVGO)
April 7, 2020 11:55 AM EDTNeedham & Company analyst Scott Berg reiterated a Buy rating and $42.00 price target on Livongo Health Inc. (NASDAQ: LVGO), saying today's positive pre-announcement suggests additional positive revisions are on the horizon.
Before the open, Livongo said it now expects revenue for the... More
